EXTRACORPOREAL PHOTOCHEMOTHERAPY INDUCES APOPTOSIS OF INFILTRATING LYMPHOID-CELLS IN PATIENTS WITH MYCOSIS-FUNGOIDES IN EARLY STAGES - A QUANTITATIVE HISTOLOGICAL STUDY
C. Miracco et al., EXTRACORPOREAL PHOTOCHEMOTHERAPY INDUCES APOPTOSIS OF INFILTRATING LYMPHOID-CELLS IN PATIENTS WITH MYCOSIS-FUNGOIDES IN EARLY STAGES - A QUANTITATIVE HISTOLOGICAL STUDY, British journal of dermatology, 137(4), 1997, pp. 549-557
Extracorporeal photochemotherapy (ExP) is a well-tolerated new form of
chemoimmunotherapy, which is considered to be effective for cutaneous
T-cell lymphoma (CTCL) and the treatment of choice for Sezary syndrom
e. Improvements have also been seen in patients with non-erythrodermic
mycosis fungoides (MF) in the early stages, even when tumour cells ar
e not detectable in the peripheral blood. In this study, we used ExP a
s a monotherapy in seven patients who had early stage (Ib) MF, and who
were no longer responsive to or had contraindications for other thera
pies. We observed a clinical improvement in the disease after 12 month
s of treatment: one patient showed a complete response, five a partial
response, and one remained stable. In each patient we compared skin b
iopsies of large plaque lesions before and after the treatment. We und
ertook a histological evaluation of the infiltrate. The lymphoid cell
proliferation and death rates were quantified using the following para
meters: lymphoid cell density (LCD), Ki67+ lymphoid cell nuclei percen
tage (Ki67+ Lcn percentage), and apoptotic index (AI). Significant dec
reases in the lymphoid cell infiltrate and in cell proliferation, and
a significant increase in AI were observed after therapy, The mean LCD
decreased from 187 +/- 33 to 34 +/- 17.7, Ki67+ Lcn mean percentage d
ecreased from 16.9 +/- 3.9 to 4.9 +/- 2.4, and the AI mean value incre
ased from 0.05 +/- 0.03 to 2.41 +/- 1.54. Our results suggest a role f
or apoptosis in the improvement of the skin lesions and are in line wi
th some reports on the mode of action of ExP. Although the way in whic
h ExP works needs to be clarified further, it does seem to stimulate a
CD8+ cell-mediated anticlonotypic activity against circulating pathog
enic clones. Furthermore, a release of tumour necrosis factor alpha (T
NF-alpha) by circulating monocytes has been demonstrated after ExP, Bo
th are known to induce cell death by apoptosis.